Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b HCV with drug resistance-associated variants in prior DAA treatment failures and human hepatocyte transplanted mice 1.Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures 2.Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized mice

k8170_2

WEKO3

lat lon distance

[[sub_check.contents]]

[[sub_radio.contents]]

Field does not validate

[[sub_attr.contents]]　

k8170_2.pdf

https://hiroshima.repo.nii.ac.jp/record/2003335/files/k8170_2.pdf

ファイル	ライセンス
k8170_2.pdf (230.9 kB) sha256 01d9ac6392159df36f21736b95341a21f341c5a5a7597a43bf51b158a96433a0

Version	Date Modified	Object File Name	File Size	File Hash Value	Contributor Name	Show/Hide

Downloads

Plays